ClinicalTrials.gg
CompletedNCT07185906Updated Sep 22, 2025

The Effect of WhatsApp-Based Education and Counseling on Breastfeeding Self-Efficacy, Body Satisfaction, Healthy Lifestyle Behaviors, and Weight Retention in Postpartum Women: A Randomized Controlled Trial

An interventional study of education in Post Partum, Breast Feeding and Body Image, sponsored by Inonu University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 49 Years. Per ClinicalTrials.gov, last updated 2025-09-22.

Sponsored by Inonu University · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jan 2025, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

Brief Summary:

This randomized controlled trial aimed to evaluate the effect of WhatsApp-based education and counseling on breastfeeding self-efficacy, body satisfaction, healthy lifestyle behaviors, and weight retention in postpartum women. The study was conducted between January and March 2025 at four Family Health Centers in Siirt, Turkey. A total of 120 postpartum women were randomly assigned to the intervention and control groups. The intervention group received an 11-week WhatsApp-based education program, including short videos and counseling sessions prepared under the guidance of the Health Promotion Model. Data were collected at baseline, 3 months, and 6 months using validated instruments: the Postnatal Breastfeeding Self-Efficacy Scale, the Body Satisfaction Scale, and the Health-Promoting Lifestyle Profile II. The primary outcomes were breastfeeding self-efficacy and body satisfaction, while secondary outcomes included healthy lifestyle behaviors and postpartum weight retention. The findings are expected to provide evidence for the effectiveness of mobile health interventions in improving maternal health outcomes during the postpartum period.

02

Conditions studied

  • Post Partum
  • Breast Feeding
  • Body Image
  • Health Behavior
  • Weight Change
  • Postpartum Period
03

In context

Breast Feeding

1,081 studies on the registry are indexed under Breast Feeding; 217 are open to participants now.

This study's enrollment of 86 is below the median of 100 across 844 interventional studies indexed under Breast Feeding.

Browse Breast Feeding studies →

Lead sponsor

Inonu University is the lead sponsor of 394 studies on the registry; 95 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Women in the postpartum period (within the first week after delivery)

      • Aged 18-49 years
      • Able to read and understand Turkish
      • Owning a smartphone with internet access and WhatsApp installed
      • Willing to participate in the study and provide

Exclusion criteria

Exclusion Criteria:

  • Women with medical complications that prevent breastfeeding (e.g., serious maternal illness, to breastfeeding)

    • Infants with conditions that prevent breastfeeding (e.g., congenital anomalies affecting sucking or swallowing)
    • Women with severe psychiatric disorders or cognitive impairments that may interfere with participation
    • Women who do not agree to participate or withdraw consent during the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Experimental: WhatsApp-based Education and Counseling

    Participants receive an 8-week WhatsApp-based education and counseling program in addition to routine postpartum care. The intervention includes short educational videos, weekly messages, and feedback provided through WhatsApp. Content covers breastfeeding techniques, recognition of infant hunger cues, milk expression and storage, management of common breastfeeding problems, healthy nutrition, body satisfaction, and postpartum weight management.

    Behavioral: education

  • No intervention
    Control Group

    Participants receive routine postpartum care provided by Family Health Centers. They do not receive any structured WhatsApp-based education or counseling.

Interventions

  • Behavioraleducation

    WhatsApp-based training was provided

06

What researchers measure

Primary outcomes

  1. Breastfeeding Self-Efficacy,

    The Postnatal Breastfeeding Self-Efficacy Scale will be used to assess mothers' confidence and self-efficacy in breastfeeding practices. Changes in mean scores between groups and over time will be evaluated.

    Time frame: Baseline, 3 months postpartum, 6 months postpartum

  2. Body Satisfaction

    The Body Satisfaction Scale will be used to measure mothers' satisfaction with their body image during the postpartum period. Changes in scores across intervention and control groups will be compared.

    Time frame: Baseline, 3 months postpartum, 6 months postpartum

Secondary outcomes

  1. Healthy Lifestyle Behaviors

    Health-promoting lifestyle behaviors will be measured using the Health-Promoting Lifestyle Profile II (HPLP-II). Total and subscale scores (nutrition, physical activity, stress management, interpersonal relations, health responsibility, and spiritual growth) will be analyzed.

    Time frame: Baseline, 3 months postpartum, 6 months postpartum

  2. Postpartum Weight Retention

    Postpartum weight retention will be calculated by subtracting the pre-pregnancy weight from the mother's postpartum weight at each measurement time. Changes will be compared between intervention and control groups.

    Time frame: Baseline, 3 months postpartum, 6 months postpartum

07

Study locations

1 site
  • ): Inonu University, Faculty of Health Sciences
    Siirt, Siirt 56100, Turkey (Türkiye)
08

References and documents

Related links

Individual participant data

Plan to share: No — The individual participant data will not be shared. Only aggregated results will be published in scientific journals.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Jun 2025, 5 months.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 5 months is below that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2025
First posted
Sep 22, 2025
StartActual
Jan 1, 2025
Primary completionActual
Jun 30, 2025
CompletionActual
Jul 30, 2025
Last update
Sep 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07185906
Lead sponsor
Inonu University
Responsible party
FİGEN BİLGİN (PhD Candidate in Women's Health and Diseases Nursing, Inonu University) — Principal investigator
First posted
Sep 22, 2025
Start date
Jan 1, 2025
Primary completion
Jun 30, 2025
Completion
Jul 30, 2025
Last update
Sep 22, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion